期刊
CANCER CELL
卷 24, 期 1, 页码 59-74出版社
CELL PRESS
DOI: 10.1016/j.ccr.2013.05.021
关键词
-
资金
- American Cancer Society [RSG-08-132-01-CDD]
- National Cancer Institute [5R01CA157510]
- American Lung Association [RT-82480-N]
- California Institute for Regenerative Medicine (CIRM) Bridges Award [TB1-01194]
Sustained tumor progression has been attributed to a distinct population of tumor-propagating cells (TPCs). To identify TPCs relevant to lung cancer pathogenesis, we investigated functional heterogeneity in tumor cells isolated from Kras-driven mouse models of non-small-cell lung cancer (NSCLC). CD24(+)ITGB4(+)Notch(hi) cells are capable of propagating tumor growth in both a clonogenic and an orthotopic serial transplantation assay. While all four Notch receptors mark TPCs, Notch3 plays a nonredundant role in tumor cell propagation in two mouse models and in human NSCLC. The TPC population is enriched after chemotherapy, and the gene signature of mouse TPCs correlates with poor prognosis in human NSCLC. The role of Notch3 in tumor propagation may provide a therapeutic target for NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据